149 related articles for article (PubMed ID: 9405384)
1. Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate.
Loo TW; Clarke DM
J Biol Chem; 1997 Dec; 272(51):31945-8. PubMed ID: 9405384
[TBL] [Abstract][Full Text] [Related]
2. Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane.
Loo TW; Clarke DM
J Biol Chem; 1999 Dec; 274(50):35388-92. PubMed ID: 10585407
[TBL] [Abstract][Full Text] [Related]
3. Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil.
Loo TW; Clarke DM
J Biol Chem; 2001 May; 276(18):14972-9. PubMed ID: 11279063
[TBL] [Abstract][Full Text] [Related]
4. Identification of residues within the drug-binding domain of the human multidrug resistance P-glycoprotein by cysteine-scanning mutagenesis and reaction with dibromobimane.
Loo TW; Clarke DM
J Biol Chem; 2000 Dec; 275(50):39272-8. PubMed ID: 11013259
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates.
Loo TW; Clarke DM
J Biol Chem; 1996 Nov; 271(44):27482-7. PubMed ID: 8910331
[TBL] [Abstract][Full Text] [Related]
6. Cross-linking of human multidrug resistance P-glycoprotein by the substrate, tris-(2-maleimidoethyl)amine, is altered by ATP hydrolysis. Evidence for rotation of a transmembrane helix.
Loo TW; Clarke DM
J Biol Chem; 2001 Aug; 276(34):31800-5. PubMed ID: 11429407
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2003 Oct; 278(41):39706-10. PubMed ID: 12909621
[TBL] [Abstract][Full Text] [Related]
8. Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 2002 Nov; 277(46):44332-8. PubMed ID: 12223492
[TBL] [Abstract][Full Text] [Related]
9. Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12.
Loo TW; Clarke DM
J Biol Chem; 1997 Aug; 272(34):20986-9. PubMed ID: 9261097
[TBL] [Abstract][Full Text] [Related]
10. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.
Loo TW; Clarke DM
Biochemistry; 1994 Nov; 33(47):14049-57. PubMed ID: 7947814
[TBL] [Abstract][Full Text] [Related]
11. Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2003 Apr; 278(16):13603-6. PubMed ID: 12609990
[TBL] [Abstract][Full Text] [Related]
12. Permanent activation of the human P-glycoprotein by covalent modification of a residue in the drug-binding site.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2003 Jun; 278(23):20449-52. PubMed ID: 12711602
[TBL] [Abstract][Full Text] [Related]
13. Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2003 Dec; 278(50):50136-41. PubMed ID: 14522974
[TBL] [Abstract][Full Text] [Related]
14. Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity.
Loo TW; Clarke DM
J Biol Chem; 1995 Sep; 270(39):22957-61. PubMed ID: 7559432
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2007 Aug; 46(32):9328-36. PubMed ID: 17636884
[TBL] [Abstract][Full Text] [Related]
16. Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities.
Loo TW; Clarke DM
J Biol Chem; 1995 Sep; 270(37):21449-52. PubMed ID: 7665554
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.
Loo TW; Bartlett MC; Clarke DM
Biochem J; 2006 Oct; 399(2):351-9. PubMed ID: 16813563
[TBL] [Abstract][Full Text] [Related]
18. Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2004 Feb; 279(9):7692-7. PubMed ID: 14670948
[TBL] [Abstract][Full Text] [Related]
19. Val133 and Cys137 in transmembrane segment 2 are close to Arg935 and Gly939 in transmembrane segment 11 of human P-glycoprotein.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2004 Apr; 279(18):18232-8. PubMed ID: 14749322
[TBL] [Abstract][Full Text] [Related]
20. The packing of the transmembrane segments of human multidrug resistance P-glycoprotein is revealed by disulfide cross-linking analysis.
Loo TW; Clarke DM
J Biol Chem; 2000 Feb; 275(8):5253-6. PubMed ID: 10681495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
